PKU RES-NEW (00618) Partners with Trivitron Healthcare to Jointly Launch Trivitron Digital AI

Stock News
01/09

PKU RES-NEW (00618) announced that its Dubai-based health business unit, ResoHealth, has entered into a strategic partnership with Trivitron Healthcare to jointly launch Trivitron Digital AI. This groundbreaking digital health initiative is designed to revolutionize healthcare delivery models in India's tier 2 and 3 cities. The collaboration specifically aims to address India's urgent demand for advanced digital infrastructure. By combining the strengths of Trivitron Healthcare and ResoHealth, Trivitron Digital AI offers innovative solutions that transform hospital operations in patient care, data management, and doctor-patient interactions, while simultaneously driving improvements in healthcare system interoperability and operational efficiency. The platform seeks to bridge the digital divide by providing hospitals with integrated cloud-based solutions, thereby enhancing operational efficiency and enabling patient-centric AI-powered diagnostics and treatment. It features a comprehensive suite of tools, including: a Laboratory Information System (LIS) that optimizes sample tracking and remote report review processes; a Web-based Picture Archiving and Communication System (Web-PACS) that facilitates image data sharing via secure online access to boost clinical collaboration; and a Personal Health Record (PHR) with a mobile-first design to empower patients in managing their own health information. These interoperable solutions are developed in compliance with global standards such as HL7, FHIR, DICOM, HIPAA, GDPR, and ABHA, and require minimal additional infrastructure, making them particularly suitable for regions with lower levels of digitalization. Trivitron Digital AI will be led by Dr. G.S.K. Velu, Chairman and Managing Director of Trivitron Healthcare, and Dr. Vas Metupalle. Dr. G.S.K. Velu emphasized the critical importance of transitioning to integrated digital ecosystems in healthcare, stating, "Through the Trivitron Digital AI platform, we are laying the foundation for mid-sized hospitals and diagnostic networks to deliver high-quality, transparent healthcare regardless of their location." Dr. Vas Metupalle elaborated on the platform's core philosophy, which focuses on patient empowerment and ease of use, aiming to achieve seamless management of health information. Beyond the Indian market, Trivitron Digital AI plans to expand into Africa, the Middle East, and Southeast Asia to address similar healthcare challenges and help local medical institutions benefit from interconnected healthcare solutions. This launch represents a significant step forward in the mission to promote the global accessibility of digital healthcare. By fusing interoperable platforms with AI-powered automation, Trivitron Digital AI is set to redefine healthcare delivery models, making them more inclusive and ensuring high-quality medical care is within reach for more people.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10